- Transcatheter Arterial Chemotherapy with Miriplatin for Hepatocellular Carcinoma Patients with Chronic Renal Failure: Report of Three Cases
-
Imai N, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H
- KMID: 2135078
- Gut Liver.
- 2013 Mar;7(2):246-251.
Miriplatin is a novel lipophilic platinum complex that was developed to treat hepatocellular carcinoma (HCC). Although HCC patients frequently have coexisting chronic renal failure, little prospective data are available regarding... -
- CITED
-
- Close
- SHARE
-
- Close
- What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study
-
Kawamura Y, Ikeda K, Fukushima , Seko Y, Hara T, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H
- KMID: 1806675
- Gut Liver.
- 2013 Sep;7(5):576-584.
BACKGROUND/AIMS: The aim of this study was to determine the pharmacodynamics of cisplatin following three different treatment procedures for intrahepatic arterial infusion therapy for hepatocellular carcinoma (HCC). METHODS: We divided 13... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan
-
Akuta N, Kawamura Y, Arase Y, Suzuki F, Sezaki H, Hosaka T, Kobayashi , Kobayashi , Saitoh S, Suzuki Y, Ikeda K, Kumada H
- KMID: 2411972
- Gut Liver.
- 2016 May;10(3):437-445.
- doi: 10.5009/gnl15163
BACKGROUND/AIMS: It is important to determine the noninvasive parameters of histological features in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the value of genetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
-
Hayashi T, Saitoh S, Fukuzawa K, Tsuji Y, Takahashi , Kawamura Y, Akuta N, Kobayashi , Ikeda K, Fujii T, Miyati T, Kumada H
- KMID: 2389356
- Gut Liver.
- 2017 Sep;11(5):674-683.
- doi: 10.5009/gnl16440
BACKGROUND/AIMS: Noninvasive liver fibrosis evaluation was performed in patients with nonalcoholic fatty liver disease (NAFLD). We used a quantitative method based on the hepatic volume acquired from gadoxetate disodium-enhanced (Gd-EOB-DTPA-enhanced)... -
- CITED
-
- Close
- SHARE
-
- Close
